Global Oncology Biosimilar Industry 2016 Deep Market Research Report
- QYR589045
- 155 Pages
- June 2016
- Pharmaceuticals
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Oncology Biosimilar market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Oncology Biosimilar industry development trends and marketing channels are analyzed.
Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.
In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview of Oncology Biosimilar
1.1 Definition and Specifications of Oncology Biosimilar
1.1.1 Definition of Oncology Biosimilar
1.1.2 Specifications of Oncology Biosimilar
1.2 Classification of Oncology Biosimilar
1.2.1 Protein
1.2.2 Hormones
1.2.3 Uucleic Acids
1.3 Applications of Oncology Biosimilar
1.4 Industry Chain Structure of Oncology Biosimilar
1.5 Industry Overview and Major Regions Status of Oncology Biosimilar
1.5.1 Industry Overview of Oncology Biosimilar
1.5.2 Global Major Regions Status of Oncology Biosimilar
1.6 Industry Policy Analysis of Oncology Biosimilar
1.7 Industry News Analysis of Oncology Biosimilar
2 Manufacturing Cost Structure Analysis of Oncology Biosimilar
2.1 Raw Material Suppliers and Price Analysis of Oncology Biosimilar
2.2 Equipment Suppliers and Price Analysis of Oncology Biosimilar
2.3 Labor Cost Analysis of Oncology Biosimilar
2.4 Other Costs Analysis of Oncology Biosimilar
2.5 Manufacturing Cost Structure Analysis of Oncology Biosimilar
2.6 Manufacturing Process Analysis of Oncology Biosimilar
3 Technical Data and Manufacturing Plants Analysis of Oncology Biosimilar
3.1 Capacity and Commercial Production Date of Global Oncology Biosimilar Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Oncology Biosimilar Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Oncology Biosimilar Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Oncology Biosimilar Major Manufacturers in 2015
4 Capacity, Production and Revenue Analysis of Oncology Biosimilar by Regions, Types and Manufacturers
4.1 Global Capacity, Production and Revenue of Oncology Biosimilar by Regions 2011-2016
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Oncology Biosimilar 2011-2016
4.3 Global Capacity, Production and Revenue of Oncology Biosimilar by Types 2011-2016
4.4 Global Capacity, Production and Revenue of Oncology Biosimilar by Manufacturers 2011-2016
5 Price, Cost, Gross and Gross Margin Analysis of Oncology Biosimilar by Regions, Types and Manufacturers
5.1 Price, Cost, Gross and Gross Margin Analysis of Oncology Biosimilar by Regions 2011-2016
5.2 Price, Cost, Gross and Gross Margin Analysis of Oncology Biosimilar by Types 2011-2016
5.3 Price, Cost, Gross and Gross Margin Analysis of Oncology Biosimilar by Manufacturers 2011-2016
6 Consumption Volume, Consumption Value and Sale Price Analysis of Oncology Biosimilar by Regions, Types and Applications
6.1 Global Consumption Volume and Consumption Value of Oncology Biosimilar by Regions 2011-2016
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Oncology Biosimilar 2011-2016
6.3 Global Consumption Volume and Consumption Value of Oncology Biosimilar by Types 2011-2016
6.4 Global Consumption Volume and Consumption Value of Oncology Biosimilar by Applications 2011-2016
6.5 Sale Price of Oncology Biosimilar by Regions 2011-2016
6.6 Sale Price of Oncology Biosimilar by Types 2011-2016
6.7 Sale Price of Oncology Biosimilar by Applications 2011-2016
6.8 Market Share Analysis of Oncology Biosimilar by Different Sale Price Levels
7 Supply, Import, Export and Consumption Analysis of Oncology Biosimilar
7.1 Supply, Consumption and Gap of Oncology Biosimilar 2011-2016
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2011-2016
7.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2011-2016
7.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2011-2016
7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2011-2016
7.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2011-2016
8 Major Manufacturers Analysis of Oncology Biosimilar
8.1 Biocon
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
8.1.4 Contact Information
8.2 Celltrion
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
8.2.4 Contact Information
8.3 Dr. Reddys Laboratories
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
8.3.4 Contact Information
8.4 F. Hoffmann-La Roche
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
8.4.4 Contact Information
8.5 Hospira
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
8.5.4 Contact Information
8.6 Mylan
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
8.6.4 Contact Information
8.7 Sandoz
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
8.7.4 Contact Information
8.8 AbbVie
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
8.8.4 Contact Information
8.9 Allergan
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
8.9.4 Contact Information
8.10 Amgen
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Capacity, Production, Price, Cost, Gross and Revenue
8.10.4 Contact Information
8.11 AstraZeneca
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Capacity, Production, Price, Cost, Gross and Revenue
8.11.4 Contact Information
8.12 Baxter
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 Capacity, Production, Price, Cost, Gross and Revenue
8.12.4 Contact Information
8.13 Biogen
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.2.1 Type I
8.13.2.2 Type II
8.13.2.3 Type III
8.13.3 Capacity, Production, Price, Cost, Gross and Revenue
8.13.4 Contact Information
8.14 BioXpress Therapeutics
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.2.1 Type I
8.14.2.2 Type II
8.14.2.3 Type III
8.14.3 Capacity, Production, Price, Cost, Gross and Revenue
8.14.4 Contact Information
8.15 Boehringer Ingelheim
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.2.1 Type I
8.15.2.2 Type II
8.15.2.3 Type III
8.15.3 Capacity, Production, Price, Cost, Gross and Revenue
8.15.4 Contact Information
8.16 Cipla
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.2.1 Type I
8.16.2.2 Type II
8.16.2.3 Type III
8.16.3 Capacity, Production, Price, Cost, Gross and Revenue
8.16.4 Contact Information
8.17 Coherus BioSciences
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.2.1 Type I
8.17.2.2 Type II
8.17.2.3 Type III
8.17.3 Capacity, Production, Price, Cost, Gross and Revenue
8.17.4 Contact Information
8.18 Coherus BioSciences
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.2.1 Type I
8.18.2.2 Type II
8.18.2.3 Type III
8.18.3 Capacity, Production, Price, Cost, Gross and Revenue
8.18.4 Contact Information
8.19 Daiichi Sankyo
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.2.1 Type I
8.19.2.2 Type II
8.19.2.3 Type III
8.19.3 Capacity, Production, Price, Cost, Gross and Revenue
8.19.4 Contact Information
9 Marketing Trader or Distributor Analysis of Oncology Biosimilar
9.1 Marketing Channels Status of Oncology Biosimilar
9.2 Traders or Distributors with Contact Information of Oncology Biosimilar by Regions
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Oncology Biosimilar
9.4 Regional Import, Export and Trade Analysis of Oncology Biosimilar
10 Industry Chain Analysis of Oncology Biosimilar
10.1 Upstream Major Raw Materials Suppliers Analysis of Oncology Biosimilar
10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Oncology Biosimilar
10.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Oncology Biosimilar by Regions
10.2 Upstream Major Equipment Suppliers Analysis of Oncology Biosimilar
10.2.1 Major Equipment Suppliers with Contact Information Analysis of Oncology Biosimilar
10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Oncology Biosimilar by Regions
10.3 Downstream Major Consumers Analysis of Oncology Biosimilar
10.3.1 Major Consumers with Contact Information Analysis of Oncology Biosimilar
10.3.2 Major Consumers with Consumption Volume Analysis of Oncology Biosimilar by Regions
10.4 Supply Chain Relationship Analysis of Oncology Biosimilar
11 Development Trend of Analysis of Oncology Biosimilar
11.1 Capacity, Production and Revenue Forecast of Oncology Biosimilar by Regions and Types
11.1.1 Global Capacity, Production and Revenue of Oncology Biosimilar by Regions 2016-2021
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Oncology Biosimilar 2016-2021
11.1.3 Global Capacity, Production and Revenue of Oncology Biosimilar by Types 2016-2021
11.2 Consumption Volume and Consumption Value Forecast of Oncology Biosimilar by Regions, Types and Applications
11.2.1 Global Consumption Volume and Consumption Value of Oncology Biosimilar by Regions 2016-2021
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Oncology Biosimilar 2016-2021
11.2.3 Global Consumption Volume and Consumption Value of Oncology Biosimilar by Types 2016-2021
11.2.4 Global Consumption Volume and Consumption Value of Oncology Biosimilar by Applications 2016-2021
11.3 Supply, Import, Export and Consumption Forecast of Oncology Biosimilar
11.3.1 Supply, Consumption and Gap of Oncology Biosimilar 2016-2021
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2016-2021
11.3.3 USA Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2016-2021
11.3.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2016-2021
11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2016-2021
11.3.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Oncology Biosimilar 2016-2021
12 New Project Investment Feasibility Analysis of Oncology Biosimilar
12.1 New Project SWOT Analysis of Oncology Biosimilar
12.2 New Project Investment Feasibility Analysis of Oncology Biosimilar
13 Conclusion of the Global Oncology Biosimilar Industry 2016 Market Research Report
Figure Picture of Oncology Biosimilar
Table Product Specifications of Oncology Biosimilar
Table Classification of Oncology Biosimilar
Figure Global Production Market Share of Oncology Biosimilar by Types in 2015
Figure Protein Picture
Table Major Manufacturers of Protein
Figure Hormones Picture
Table Major Manufacturers of Hormones
Figure Uucleic Acids Picture
Table Major Manufacturers of Uucleic Acids
Table Applications of Oncology Biosimilar
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Applications in 2015
Figure Industry Chain Structure of Oncology Biosimilar
Table Global Oncology Biosimilar Major Manufacturers
Table Global Major Regions Oncology Biosimilar Development Status
Table Industry Policy of Oncology Biosimilar
Table Industry News List of Oncology Biosimilar
Table Raw Material Suppliers and Price Analysis
Table Equipment Suppliers and Price Analysis
Table Manufacturing Cost Structure Analysis of Oncology Biosimilar in 2015
Figure Manufacturing Process Analysis of Oncology Biosimilar
Table Capacity (Unit) and Commercial Production Date of Global Oncology Biosimilar Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Oncology Biosimilar Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Oncology Biosimilar Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Oncology Biosimilar Major Manufacturers in 2015
Table Global Capacity (Unit) of Oncology Biosimilar by Regions 2011-2016
Figure Global Capacity Market Share of Oncology Biosimilar by Regions in 2011
Figure Global Capacity Market Share of Oncology Biosimilar by Regions in 2015
Table Global Production (Unit) of Oncology Biosimilar by Regions 2011-2016
Figure Global Production Market Share of Oncology Biosimilar by Regions in 2011
Figure Global Production Market Share of Oncology Biosimilar by Regions in 2015
Table Global Revenue (M USD) of Oncology Biosimilar by Regions 2011-2016
Figure Global Revenue Market Share of Oncology Biosimilar by Regions in 2011
Figure Global Revenue Market Share of Oncology Biosimilar by Regions in 2015
Figure Global Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure Global Capacity Utilization Rate of Oncology Biosimilar 2011-2016
Figure Global Revenue (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Figure USA Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure USA Capacity Utilization Rate of Oncology Biosimilar 2011-2016
Figure USA Revenue (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Figure EU Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure EU Capacity Utilization Rate of Oncology Biosimilar 2011-2016
Figure EU Revenue (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Figure China Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure China Capacity Utilization Rate of Oncology Biosimilar 2011-2016
Figure China Revenue (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Figure Japan Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure Japan Capacity Utilization Rate of Oncology Biosimilar 2011-2016
Figure Japan Revenue (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Table Global Capacity (Unit) of Oncology Biosimilar by Types 2011-2016
Figure Global Capacity Market Share of Oncology Biosimilar by Types in 2011
Figure Global Capacity Market Share of Oncology Biosimilar by Types in 2015
Table Global Production (Unit) of Oncology Biosimilar by Types 2011-2016
Figure Global Production Market Share of Oncology Biosimilar by Types in 2011
Figure Global Production Market Share of Oncology Biosimilar by Types in 2015
Table Global Revenue (M USD) of Oncology Biosimilar by Types 2011-2016
Figure Global Revenue Market Share of Oncology Biosimilar by Types in 2011
Figure Global Revenue Market Share of Oncology Biosimilar by Types in 2015
Table Global and Major Manufacturers Capacity (Unit) of Oncology Biosimilar 2011-2016
Table Global Capacity Market Share of Oncology Biosimilar Major Manufacturers 2011-2016
Figure Global Capacity Market Share of Oncology Biosimilar Major Manufacturers in 2011
Figure Global Capacity Market Share of Oncology Biosimilar Major Manufacturers in 2015
Table Global and Major Manufacturers Production (Unit) of Oncology Biosimilar 2011-2016
Table Global Production Market Share of Oncology Biosimilar Major Manufacturers 2011-2016
Figure Global Production Market Share of Oncology Biosimilar Major Manufacturers in 2011
Figure Global Production Market Share of Oncology Biosimilar Major Manufacturers in 2015
Table Global and Major Manufacturers Revenue (M USD) of Oncology Biosimilar 2011-2016
Table Global Revenue Market Share of Oncology Biosimilar Major Manufacturers 2011-2016
Figure Global Revenue Market Share of Oncology Biosimilar Major Manufacturers in 2011
Figure Global Revenue Market Share of Oncology Biosimilar Major Manufacturers in 2015
Table Price (USD/Unit) of Oncology Biosimilar by Regions 2011-2016
Figure Price (USD/Unit) of Oncology Biosimilar by Regions in 2015
Table Cost (USD/Unit) of Oncology Biosimilar by Regions 2011-2016
Figure Cost (USD/Unit) of Oncology Biosimilar by Regions in 2015
Table Gross (USD/Unit) of Oncology Biosimilar by Regions 2011-2016
Figure Gross (USD/Unit) of Oncology Biosimilar by Regions in 2015
Table Gross Margin of Oncology Biosimilar by Regions 2011-2016
Figure Gross Margin of Oncology Biosimilar by Regions in 2015
Table Price (USD/Unit) of Oncology Biosimilar by Types 2011-2016
Figure Price (USD/Unit) of Oncology Biosimilar by Types in 2015
Table Cost (USD/Unit) of Oncology Biosimilar by Types 2011-2016
Figure Cost (USD/Unit) of Oncology Biosimilar by Types in 2015
Table Gross (USD/Unit) of Oncology Biosimilar by Types 2011-2016
Figure Gross (USD/Unit) of Oncology Biosimilar by Types in 2015
Table Gross Margin of Oncology Biosimilar by Types 2011-2016
Figure Gross Margin of Oncology Biosimilar by Types in 2015
Table Price (USD/Unit) of Oncology Biosimilar by Manufacturers 2011-2016
Figure Price (USD/Unit) of Oncology Biosimilar by Manufacturers in 2015
Table Cost (USD/Unit) of Oncology Biosimilar by Manufacturers 2011-2016
Figure Cost (USD/Unit) of Oncology Biosimilar by Manufacturers in 2015
Table Gross (USD/Unit) of Oncology Biosimilar by Manufacturers 2011-2016
Figure Gross (USD/Unit) of Oncology Biosimilar by Manufacturers in 2015
Table Gross Margin of Oncology Biosimilar by Manufacturers 2011-2016
Figure Gross Margin of Oncology Biosimilar by Manufacturers in 2015
Table Global Consumption Volume (Unit) of Oncology Biosimilar by Regions 2011-2016
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Regions in 2011
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Regions in 2015
Table Global Consumption Value (M USD) of Oncology Biosimilar by Regions 2011-2016
Figure Global Consumption Value Market Share of Oncology Biosimilar by Regions in 2011
Figure Global Consumption Value Market Share of Oncology Biosimilar by Regions in 2015
Figure Global Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure Global Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Figure USA Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure USA Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Figure EU Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure EU Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Figure China Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure China Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Figure Japan Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2011-2016
Figure Japan Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2011-2016
Table Global Consumption Volume (Unit) of Oncology Biosimilar by Types 2011-2016
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Types in 2011
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Types in 2015
Table Global Consumption Value (M USD) of Oncology Biosimilar by Types 2011-2016
Figure Global Consumption Value Market Share of Oncology Biosimilar by Types in 2011
Figure Global Consumption Value Market Share of Oncology Biosimilar by Types in 2015
Table Global Consumption Volume (Unit) of Oncology Biosimilar by Applications 2011-2016
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Applications in 2011
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Applications in 2015
Table Global Consumption Value (M USD) of Oncology Biosimilar by Applications 2011-2016
Figure Global Consumption Value Market Share of Oncology Biosimilar by Applications in 2011
Figure Global Consumption Value Market Share of Oncology Biosimilar by Applications in 2015
Table Sale Price (USD/Unit) of Oncology Biosimilar by Regions 2011-2016
Figure Sale Price (USD/Unit) of Oncology Biosimilar by Regions in 2015
Table Sale Price (USD/Unit) of Oncology Biosimilar by Types 2011-2016
Figure Sale Price (USD/Unit) of Oncology Biosimilar by Types in 2015
Table Sale Price (USD/Unit) of Oncology Biosimilar by Applications 2011-2016
Figure Sale Price (USD/Unit) of Oncology Biosimilar by Applications in 2015
Table Market Share of Oncology Biosimilar by Different Sale Price Levels
Table Global Supply, Consumption and Gap of Oncology Biosimilar 2011-2016 (Unit)
Table USA Supply, Consumption and Gap of Oncology Biosimilar 2011-2016 (Unit)
Table EU Supply, Consumption and Gap of Oncology Biosimilar 2011-2016 (Unit)
Table China Supply, Consumption and Gap of Oncology Biosimilar 2011-2016 (Unit)
Table Japan Supply, Consumption and Gap of Oncology Biosimilar 2011-2016 (Unit)
Table Global Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2011-2016
Table USA Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2011-2016
Table USA Supply, Import, Export and Consumption of Oncology Biosimilar 2011-2016 (Unit)
Table EU Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2011-2016
Table EU Supply, Import, Export and Consumption of Oncology Biosimilar 2011-2016 (Unit)
Table China Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2011-2016
Table China Supply, Import, Export and Consumption of Oncology Biosimilar 2011-2016 (Unit)
Table Japan Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2011-2016
Table Japan Supply, Import, Export and Consumption of Oncology Biosimilar 2011-2016 (Unit)
Table Biocon Information List
Figure Oncology Biosimilar Picture and Specifications of Biocon
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biocon 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Biocon 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Biocon 2011-2016
Table Celltrion Information List
Figure Oncology Biosimilar Picture and Specifications of Celltrion
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Celltrion 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Celltrion 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Celltrion 2011-2016
Table Dr. Reddy's Laboratories Information List
Figure Oncology Biosimilar Picture and Specifications of Dr. Reddy's Laboratories
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Dr. Reddy's Laboratories 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Dr. Reddy's Laboratories 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Dr. Reddy's Laboratories 2011-2016
Table F. Hoffmann-La Roche Information List
Figure Oncology Biosimilar Picture and Specifications of F. Hoffmann-La Roche
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of F. Hoffmann-La Roche 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of F. Hoffmann-La Roche 2011-2016
Table Hospira Information List
Figure Oncology Biosimilar Picture and Specifications of Hospira
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Hospira 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Hospira 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Hospira 2011-2016
Table Mylan Information List
Figure Oncology Biosimilar Picture and Specifications of Mylan
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Mylan 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Mylan 2011-2016
Table Sandoz Information List
Figure Oncology Biosimilar Picture and Specifications of Sandoz
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sandoz 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Sandoz 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Sandoz 2011-2016
Table AbbVie Information List
Figure Oncology Biosimilar Picture and Specifications of AbbVie
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of AbbVie 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of AbbVie 2011-2016
Table Allergan Information List
Figure Oncology Biosimilar Picture and Specifications of Allergan
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Allergan 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Allergan 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Allergan 2011-2016
Table Amgen Information List
Figure Oncology Biosimilar Picture and Specifications of Amgen
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Amgen 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Amgen 2011-2016
Table AstraZeneca Information List
Figure Oncology Biosimilar Picture and Specifications of AstraZeneca
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of AstraZeneca 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of AstraZeneca 2011-2016
Table Baxter Information List
Figure Oncology Biosimilar Picture and Specifications of Baxter
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Baxter 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Baxter 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Baxter 2011-2016
Table Biogen Information List
Figure Oncology Biosimilar Picture and Specifications of Biogen
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biogen 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Biogen 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Biogen 2011-2016
Table BioXpress Therapeutics Information List
Figure Oncology Biosimilar Picture and Specifications of BioXpress Therapeutics
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of BioXpress Therapeutics 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of BioXpress Therapeutics 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of BioXpress Therapeutics 2011-2016
Table Boehringer Ingelheim Information List
Figure Oncology Biosimilar Picture and Specifications of Boehringer Ingelheim
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Boehringer Ingelheim 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Boehringer Ingelheim 2011-2016
Table Cipla Information List
Figure Oncology Biosimilar Picture and Specifications of Cipla
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cipla 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Cipla 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Cipla 2011-2016
Table Coherus BioSciences Information List
Figure Oncology Biosimilar Picture and Specifications of Coherus BioSciences
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Coherus BioSciences 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Coherus BioSciences 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Coherus BioSciences 2011-2016
Table Coherus BioSciences Information List
Figure Oncology Biosimilar Picture and Specifications of Coherus BioSciences
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Coherus BioSciences 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Coherus BioSciences 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Coherus BioSciences 2011-2016
Table Daiichi Sankyo Information List
Figure Oncology Biosimilar Picture and Specifications of Daiichi Sankyo
Table Oncology Biosimilar Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Daiichi Sankyo 2011-2016
Figure Oncology Biosimilar Capacity (Unit), Production (Unit) and Growth Rate of Daiichi Sankyo 2011-2016
Figure Oncology Biosimilar Production (Unit) and Global Market Share of Daiichi Sankyo 2011-2016
Figure Marketing Channels of Oncology Biosimilar
Table Traders or Distributors with Contact Information of Oncology Biosimilar by Regions
Table Ex-work Price, Channel Price and End Buyer Price of Oncology Biosimilar (USD/Unit)
Table Regional Import, Export, and Trade of Oncology Biosimilar (Unit)
Table Flow of International Trade in 2015
Table Major Raw Materials Suppliers with Contact Information of Oncology Biosimilar
Table Major Raw Materials Suppliers with Supply Volume of Oncology Biosimilar by Regions
Table Major Equipment Suppliers with Contact Information of Oncology Biosimilar
Table Major Equipment Suppliers with Product Pictures of Oncology Biosimilar by Regions
Table Major Consumers with Contact Information of Oncology Biosimilar
Table Major Consumers with Consumption Volume of Oncology Biosimilar by Regions
Figure Supply Chain Relationship Analysis of Oncology Biosimilar
Table Global Capacity (Unit) of Oncology Biosimilar by Regions 2016-2021
Figure Global Capacity Market Share of Oncology Biosimilar by Regions in 2016
Figure Global Capacity Market Share of Oncology Biosimilar by Regions in 2021
Table Global Production (Unit) of Oncology Biosimilar by Regions 2016-2021
Figure Global Production Market Share of Oncology Biosimilar by Regions in 2016
Figure Global Production Market Share of Oncology Biosimilar by Regions in 2021
Table Global Revenue (M USD) of Oncology Biosimilar by Regions 2016-2021
Figure Global Revenue Market Share of Oncology Biosimilar by Regions in 2016
Figure Global Revenue Market Share of Oncology Biosimilar by Regions in 2021
Figure Global Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure Global Capacity Utilization Rate of Oncology Biosimilar 2016-2021
Figure Global Revenue (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Figure USA Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure USA Capacity Utilization Rate of Oncology Biosimilar 2016-2021
Figure USA Revenue (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Figure EU Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure EU Capacity Utilization Rate of Oncology Biosimilar 2016-2021
Figure EU Revenue (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Figure China Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure China Capacity Utilization Rate of Oncology Biosimilar 2016-2021
Figure China Revenue (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Figure Japan Capacity (Unit), Production (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure Japan Capacity Utilization Rate of Oncology Biosimilar 2016-2021
Figure Japan Revenue (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Table Global Capacity (Unit) of Oncology Biosimilar by Types 2016-2021
Figure Global Capacity Market Share of Oncology Biosimilar by Types in 2016
Figure Global Capacity Market Share of Oncology Biosimilar by Types in 2021
Table Global Production (Unit) of Oncology Biosimilar by Types 2016-2021
Figure Global Production Market Share of Oncology Biosimilar by Types in 2016
Figure Global Production Market Share of Oncology Biosimilar by Types in 2021
Table Global Revenue (M USD) of Oncology Biosimilar by Types 2016-2021
Figure Global Revenue Market Share of Oncology Biosimilar by Types in 2016
Figure Global Revenue Market Share of Oncology Biosimilar by Types in 2021
Table Global Consumption Volume (Unit) of Oncology Biosimilar by Regions 2016-2021
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Regions in 2016
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Regions in 2021
Table Global Consumption Value (M USD) of Oncology Biosimilar by Regions 2016-2021
Figure Global Consumption Value Market Share of Oncology Biosimilar by Regions in 2016
Figure Global Consumption Value Market Share of Oncology Biosimilar by Regions in 2021
Figure Global Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure Global Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Figure USA Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure USA Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Figure EU Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure EU Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Figure China Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure China Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Figure Japan Consumption Volume (Unit) and Growth Rate of Oncology Biosimilar 2016-2021
Figure Japan Consumption Value (M USD) and Growth Rate of Oncology Biosimilar 2016-2021
Table Global Consumption Volume (Unit) of Oncology Biosimilar by Types 2016-2021
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Types in 2016
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Types in 2021
Table Global Consumption Value (M USD) of Oncology Biosimilar by Types 2016-2021
Figure Global Consumption Value Market Share of Oncology Biosimilar by Types in 2016
Figure Global Consumption Value Market Share of Oncology Biosimilar by Types in 2021
Table Global Consumption Volume (Unit) of Oncology Biosimilar by Applications 2016-2021
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Applications in 2016
Figure Global Consumption Volume Market Share of Oncology Biosimilar by Applications in 2021
Table Global Consumption Value (M USD) of Oncology Biosimilar by Applications 2016-2021
Figure Global Consumption Value Market Share of Oncology Biosimilar by Applications in 2016
Figure Global Consumption Value Market Share of Oncology Biosimilar by Applications in 2021
Table Global Supply, Consumption and Gap of Oncology Biosimilar 2016-2021 (Unit)
Table USA Supply, Consumption and Gap of Oncology Biosimilar 2016-2021 (Unit)
Table EU Supply, Consumption and Gap of Oncology Biosimilar 2016-2021 (Unit)
Table China Supply, Consumption and Gap of Oncology Biosimilar 2016-2021 (Unit)
Table Japan Supply, Consumption and Gap of Oncology Biosimilar 2016-2021 (Unit)
Table Global Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2016-2021
Table USA Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2016-2021
Table USA Supply, Import, Export and Consumption of Oncology Biosimilar 2016-2021 (Unit)
Table EU Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2016-2021
Table EU Supply, Import, Export and Consumption of Oncology Biosimilar 2016-2021 (Unit)
Table China Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2016-2021
Table China Supply, Import, Export and Consumption of Oncology Biosimilar 2016-2021 (Unit)
Table Japan Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Oncology Biosimilar 2016-2021
Table Japan Supply, Import, Export and Consumption of Oncology Biosimilar 2016-2021 (Unit)
Table New Project SWOT Analysis of Oncology Biosimilar
Table New Project Investment Feasibility Analysis of Oncology Biosimilar
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
